CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients

Clinical trial NCT05994690 · RECRUITING

Trial details

NCT number: NCT05994690
Sponsor: Princess Maxima Center for Pediatric Oncology
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia in Children

Start date: 2023-07-14
Primary completion: 2031-03-01
Enrollment: 905

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.